Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal build update and does not change visible content on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.4.3 was added, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page shows a new revision tag (v3.4.2) and removal of a prior government funding notice; no changes to the study details, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange DetectedA system notice about government funding lapse and NIH Clinical Center operations was added, and the site version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check86 days agoChange DetectedGlossary toggle was added, and QC/version metadata updated to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The older QC wording and 'No FEAR Act data' phrasing were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.